We use cookies to enhance the usability of our website. If you continue, we'll assume that you are happy to receive all cookies. More information. Don't show this again.
Malignant cells showed weak to moderate nuclear immunoreactivity. A few cases of urothelial and ovarian cancers as well as malignant melanomas and lymphomas showed strong positivity.